Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code C96.21

Aggressive systemic mastocytosis (ASM) is a rare disorder characterized by the abnormal proliferation of mast cells, accumulating in tissues and potentially affecting various organs.

Use additional codes to specify any organ involvement or complications related to ASM.

The medical necessity for ASM treatment is based on the patient's symptoms and the impact of the disease on their quality of life.Treatment aims to alleviate symptoms and manage organ dysfunction associated with ASM.

Diagnosis of ASM involves evaluating patient history, signs and symptoms, physical examination, and laboratory tests (CBC, peripheral smear, blood chemistries, serum tryptase levels). Bone marrow biopsy or fine needle aspiration may also be performed, along with imaging studies like DEXA scans and ultrasound. Treatment focuses on symptom relief, including topical steroids for skin lesions and systemic antihistamines.

In simple words: Aggressive systemic mastocytosis (ASM) is a rare disease where too many mast cells (a type of white blood cell) grow in the body. These cells build up in tissues and organs like the spleen, liver, and bone marrow. They release a substance called histamine, causing allergic reactions like itching, rashes, and stomach problems.

Aggressive systemic mastocytosis (ASM) involves the uncontrolled multiplication of mast cells, which accumulate in body tissues and may impact organs such as the spleen, small intestine, liver, and bone marrow. These mast cells release excessive histamine, leading to allergic reactions in the affected tissues.

Example 1: A patient presents with severe itching, abdominal pain, recurring rashes, and flushing. After laboratory tests and a bone marrow biopsy, they are diagnosed with aggressive systemic mastocytosis., A patient experiences persistent diarrhea, nausea, vomiting, and abdominal discomfort. Further investigation reveals organ enlargement and dysfunction, leading to a diagnosis of ASM., A patient with known mastocytosis develops worsening symptoms and organ involvement, indicating a progression to aggressive systemic mastocytosis.

Documentation should include patient history, physical exam findings, laboratory results (CBC, peripheral smear, blood chemistries, serum tryptase levels), bone marrow biopsy or fine needle aspiration findings, and imaging study results (DEXA scan, ultrasound). Details of symptom management, including medications like topical steroids and antihistamines, should also be documented.

** ASM carries a poor prognosis. There is no specific cure, and treatment focuses on managing symptoms and complications.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.